Therefore, we subcutaneously inoculated CT26shSTING into the left leg of BALB/c mice and monitored them for 10 days to assess the therapeutic effect of MSCs combined with radiotherapy on CRC by overcoming the cGAS/STING deficiency. The gene discussed is STING1; the disease is colorectal carcinoma.